Pancreatic islet cell replacement therapy is a promising strategy for patients with type 1 diabetes mellitus, but the scarcity of organ donors and need for immunosuppression hamper its wide application. Huang and colleagues developed an efficient method to redirect the fate of primary human gastric stem cells, generated from stomach tissue, towards insulin-producing β-cells.
This is a preview of subscription content, log in via an institution to check access.
References
de Koning, E. J. P. & Carlotti, F. Stem cell-based islet replacement therapy in diabetes: a road trip that reached the clinic. Cell Stem Cell 28, 2044–2046 (2021).
Markmann, J. F. et al. Stem cell-derived, fully differentiated islet cells for type 1 diabetes. Diabetes 71 (Supp. 1), 259-OR (2022).
Huang, X. et al. Stomach-derived human insulin-secreting organoids restore glucose homeostasis. Nat. Cell Biol. 25, 778–786 (2023).
Ariyachet, C. et al. Reprogrammed stomach tissue as a renewable source of functional β cells for blood glucose regulation. Cell Stem Cell 18, 410–421 (2016).
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627–632 (2008).
Xiao, X. et al. Endogenous reprogramming of alpha cells into beta cells, induced by viral gene therapy, reverses autoimmune diabetes. Cell Stem Cell 22, 78–90.e4 (2018).
Pepper, A. R. et al. Posttransplant characterization of long-term functional hESC-derived pancreatic endoderm grafts. Diabetes 68, 953–962 (2019).
Sander, M. et al. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127, 5533–5540 (2000).
Rezania, A. et al. Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo. Stem Cells 31, 2432–2442 (2013).
Xu, E. E. et al. SOX4 cooperates with neurogenin 3 to regulate endocrine pancreas formation in mouse models. Diabetologia 58, 1013–1023 (2015).
Acknowledgements
F.C. and E.J.P.d.K. acknowledge the support of research funding from the RegMedXB consortium, DON foundation, the Dutch Diabetes Research Foundation, Bontius Foundation, JDRF and Novo Nordisk Foundation Center for Stem Cell Medicine (NNF21CC0073729).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
de Koning, E.J.P., Carlotti, F. Human stomach tissue as alternative source of insulin-producing cells. Nat Rev Endocrinol 19, 503–504 (2023). https://doi.org/10.1038/s41574-023-00867-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-023-00867-8
- Springer Nature Limited